Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Adile

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Pain Practice : the Official Journal of World Institute of Pain|November 13, 2014
Pain intensity as prognostic factor in cancer pain managementSebastiano Mercadante, Giampiero Porzio, Claudio Adile, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 15, 2013
Orphan symptoms in advanced cancer patients followed at homeSebastiano Mercadante, Giampiero Porzio, Alessandro Valle, et al.
Journal of Pain and Symptom Management|October 30, 2012
Opioid switching in patients with advanced cancer followed at home. A retrospective analysisSebastiano Mercadante, Alessandro Valle, Giampiero Porzio, et al.
Current Medical Research and Opinion|June 14, 2014
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer painSebastiano Mercadante, Giampiero Porzio, Claudio Adile, et al.
Current Medical Research and Opinion|December 4, 2012
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patientsSebastiano Mercadante, Claudio Adile, Riccardo Torta, et al.
Journal of Pain and Symptom Management|August 26, 2015
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison StudySebastiano Mercadante, Claudio Adile, Arturo Cuomo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2018
Characteristics and care pathways of advanced cancer patients in a palliative-supportive care unit and an oncological wardSebastiano Mercadante, Paolo Marchetti, Claudio Adile, et al.
Current Medical Research and Opinion|April 7, 2012
Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional dosesSebastiano Mercadante, Antonio Gatti, Giampiero Porzio, et al.
The Oncologist|April 5, 2022
Methadone as First-line Opioid for the Management of Cancer PainSebastiano Mercadante, Claudio Adile, Patrizia Ferrera, et al.
Current Medical Research and Opinion|April 2, 2013
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioidsSebastiano Mercadante, Giampiero Porzio, Federica Aielli, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Pain Practice : the Official Journal of World Institute of Pain|November 13, 2014
Pain intensity as prognostic factor in cancer pain managementSebastiano Mercadante, Giampiero Porzio, Claudio Adile, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 15, 2013
Orphan symptoms in advanced cancer patients followed at homeSebastiano Mercadante, Giampiero Porzio, Alessandro Valle, et al.
Journal of Pain and Symptom Management|October 30, 2012
Opioid switching in patients with advanced cancer followed at home. A retrospective analysisSebastiano Mercadante, Alessandro Valle, Giampiero Porzio, et al.
Current Medical Research and Opinion|June 14, 2014
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer painSebastiano Mercadante, Giampiero Porzio, Claudio Adile, et al.
Current Medical Research and Opinion|December 4, 2012
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patientsSebastiano Mercadante, Claudio Adile, Riccardo Torta, et al.
Journal of Pain and Symptom Management|August 26, 2015
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison StudySebastiano Mercadante, Claudio Adile, Arturo Cuomo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2018
Characteristics and care pathways of advanced cancer patients in a palliative-supportive care unit and an oncological wardSebastiano Mercadante, Paolo Marchetti, Claudio Adile, et al.
Current Medical Research and Opinion|April 7, 2012
Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional dosesSebastiano Mercadante, Antonio Gatti, Giampiero Porzio, et al.
The Oncologist|April 5, 2022
Methadone as First-line Opioid for the Management of Cancer PainSebastiano Mercadante, Claudio Adile, Patrizia Ferrera, et al.
Current Medical Research and Opinion|April 2, 2013
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioidsSebastiano Mercadante, Giampiero Porzio, Federica Aielli, et al.
Pageof 8